John Reese

|RSS

John P. Reese is founder and CEO of Validea.com, an investment research firm, and Validea Capital Management, an asset management firm serving affluent investors and companies. He is also co-author of two investing books, including The Guru Investor: How to Beat the Market Using History's Best Investment Strategies (Wiley).Expand

Before Validea, Reese was vice president of information technology for GE Capital ITS, president and CEO of Micro Networks of America, a networking firm, and marketing manager of electronics at Coleco.

Reese holds a master's of business administration from Harvard Business School and a bachelor's degree in computer science from the Massachusetts Institute of Technology.Collapse

By

John Reese

 | Aug 29, 2013 | 6:00 PM EDT

Yes, you heard that right, and here are three names to consider.

By

John Reese

 | Aug 22, 2013 | 5:30 PM EDT

Two gems in the aerospace and defense industry are worth consideration.

By

John Reese

 | Aug 2, 2013 | 9:30 AM EDT

Auto revival is good for these dealers, aftermarket companies.

By

John Reese

 | Jul 26, 2013 | 11:00 AM EDT

While the sector struggles, these two names are outperforming.

By

John Reese

 | Jul 19, 2013 | 10:00 AM EDT

They pass the tests of some leading stock investors.

By

John Reese

 | Jul 11, 2013 | 2:00 PM EDT

Two stocks at opposite ends of the consumer-products spectrum.

By

John Reese

 | Jun 27, 2013 | 6:00 PM EDT

If you want to be defensive, consider these solid performers.

By

John Reese

 | Jun 21, 2013 | 7:00 AM EDT

These three unemployment agencies are ripe now.

By

John Reese

 | Jun 13, 2013 | 5:00 PM EDT

Three auto-related stocks you can ride on an industry comeback.

By

John Reese

 | Jun 7, 2013 | 12:30 PM EDT

This wireless operator offers a great entry into the market.

I am still watching MON for a possible reversal against the time/price parameters. So far...
Market stages nice comeback from early losses to end basically flat. Gilead Sciences (GILD...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...
Cramer:  
DRI

Going to $47 without Otis...

BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.